https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

IDIVAL participates in the launch meeting of the European project Halt‑RONIN to advance research on liver inflammation

7 de August de 2026

The Marqués de Valdecilla Research Institute (IDIVAL) took part in the Kick‑off Meeting of the European project Halt‑RONIN, held at the Royal University College María Cristina in San Lorenzo de El Escorial (Madrid) and coordinated by the Complutense University of Madrid (UCM). This meeting brought together the international partners of the consortium with the aim […]

Read more →

IDIVAL’s prototyping service develops 3D‑printed solutions to humanize pediatric care at Valdecilla

3 de August de 2026

Collaboration between engineers, physicians and nursing staff has made it possible to create personalized devices that reduce children’s anxiety during chemotherapy and improve their well‑being and safety. Innovation can emerge from everyday needs identified by healthcare professionals themselves. The partnership between the Prototyping Unit of IDIVAL’s Innovation Area and the Hematology and Advanced Therapies team […]

Read more →

Two studies assess the impact of a workshop on birth and death aimed at children, families, and educational centers

29 de July de 2026

The IDIVAL Nursing Group analyzes the effects of the intervention in civic centers and primary schools The Nursing Group of the Marqués de Valdecilla Research Institute (IDIVAL) has evaluated the impact of the workshop “Being born, dying, loving, caring”, an intervention delivered by midwives and aimed at children aged 6 to 12, implemented in two […]

Read more →

A nanoplasmonic biosensor moves toward more precise surgery for brain metastases

21 de July de 2026

The study, published in the Journal of Neuro-Oncology, demonstrates the potential of this technology to complement intraoperative identification of tumor margins without using external markers. A team of researchers affiliated with IDIVAL, the Marqués de Valdecilla University Hospital, and the University of Cantabria has shown that a nanoplasmonic biosensor is capable of distinguishing tumor tissue […]

Read more →

Cantabria takes part in the general assembly of the joint action preventNCD in Rome

17 de July de 2026

The General Assembly of the Joint Action PreventNCD (JA PreventNCD) was held in Rome, attended on behalf of the Marqués de Valdecilla Health Research Institute (IDIVAL) and the Health Department of the Government of Cantabria by Ana P. Medina, Blanca Benito, María Zúñiga, and Carlos Fernández Viadero. During the meeting, participants reviewed the project’s progress […]

Read more →

IDIVAL and the Directorate-General for Public Health present at the ECTOH Conference in Milan results on exposure to second-hand smoke in households in Cantabria

14 de July de 2026

Cantabria took part in the international ECTOH (European Conference on Tobacco or Health), held in Milan, with the oral presentation “Exposure to second-hand tobacco smoke in households in Cantabria: the influence of minors on indoor smoking behaviours.” The abstract, selected by the conference’s scientific committee for oral communication format, was presented by Ana P. Medina […]

Read more →

IDIVAL takes part in a European meeting in Mérida to promote the transfer of JACARDI results into healthcare systems

9 de July de 2026

The Nursing Research Group contributes to shaping the sustainability strategy for the European pilot projects on self-management of cardiovascular diseases and diabetes. The Marqués de Valdecilla Health Research Institute (IDIVAL), through its Nursing Research Group, co-leader of Work Package 10 (WP10) of the European JACARDI project, participated in the third Learning Session held in Mérida […]

Read more →

IDIVAL researchers identify a key mutation to improve the diagnosis and treatment of an aggressive type of lymphoma

8 de July de 2026

Researchers from the Translational Hematopathology Research Group at the Marqués de Valdecilla Research Institute (IDIVAL) have demonstrated the value of a genetic alteration in the molecular classification of diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin lymphoma in adults. The findings, published in Virchows Archiv, show that the MYD88L265P mutation is strongly […]

Read more →

IDIVAL takes part in the third CIRCE-JA Consortium Meeting in Rome

6 de July de 2026

The Health Research Institute Valdecilla (IDIVAL) participated in the third consortium meeting of the European project CIRCE-JA, held on 25–26 May 2026 in Rome at the headquarters of AGENAS (Agenzia Nazionale per i Servizi Sanitari Regionali). The meeting brought together the organisations participating in the Joint Action to review the project’s progress, share the status […]

Read more →

A study confirms the safety and reliability of organ preservation techniques in donors after circulatory death, a key aspect for organ donation

3 de July de 2026

Doctors Eduardo Miñambres, from Marqués de Valdecilla University Hospital, and Mario Royo-Villanova, from Virgen de la Arrixaca University Hospital in Murcia, lead the study “Clinical Evidence of the Absence of Brain Perfusion During Thoraco-Abdominal Normothermic Regional Perfusion in Donation After Circulatory Determination of Death”, recently published in the scientific journal American Journal of Transplantation. The […]

Read more →
Idival
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.